Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Cistanche, a traditional Chinese medicinal herb, has been explored in recent years for its potential role in supporting bone health and treating osteoporosis. The scientific evidence primarily comes from preclinical studies (in vitro and animal models) rather than robust human clinical trials. Research suggests that extracts from Cistanche deserticola and related species may have osteoprotective effects. These effects are likely mediated by several mechanisms: Cistanche is rich in phenylethanoid glycosides (such as echinacoside and acteoside), which display antioxidant and anti-inflammatory properties. These compounds have demonstrated the ability to promote osteoblast (bone-forming cell) activity and inhibit osteoclast (bone-resorbing cell) differentiation in laboratory studies. Additionally, Cistanche appears to modulate pathways involved in bone turnover, such as the RANK/RANKL/OPG pathway, which is crucial in the development of osteoporosis. Animal studies have shown that supplementation with Cistanche extracts can improve bone mineral density and bone microarchitecture in ovariectomized rats (a common model for postmenopausal osteoporosis). However, direct evidence from human clinical trials is lacking, and the safety, efficacy, and optimal dosing of Cistanche for osteoporosis in humans remain to be established. Thus, while there is a scientific basis for its potential benefit, the evidence is currently limited and preliminary. More rigorous clinical research is necessary to validate its effectiveness in humans.

More about cistanche
More about Osteoporosis

Other ingredients used for Osteoporosis

Other health conditions supported by cistanche

Products containing cistanche